Infectious burden and risk of stroke

The northern manhattan study

Mitchell S V Elkind, Pankajavalli Ramakrishnan, Yeseon P. Moon, Bernadette Boden-Albala, Khin M. Liu, Steve L. Spitalnik, Tanja Rundek, Ralph L. Sacco, Myunghee C. Paik

Research output: Contribution to journalArticle

Abstract

Objective: To determine the association between a composite measure of serological test results for common infections (Chlamydia pneumoniae, Helicobacter pylori, cytomegalovirus, and herpes simplex virus 1 and 2) and stroke risk in a prospective cohort study. Design: Prospective cohort followed up longitudinally for median 8 years. Setting: Northern Manhattan Study. Patients: Randomly selected stroke-free participants from a multiethnic urban community. Main Outcome Measure: Incident stroke and other vascular events. Results: All 5 infectious serological results were available from baseline samples in 1625 participants (mean [SD] age, 68.4 [10.1] years; 64.9% women). Cox proportional hazards models were used to estimate associations of each positive serological test result with stroke. Individual parameter estimates were then combined into a weighted index of infectious burden and used to calculate hazard ratios and confidence intervals for association with risk of stroke and other outcomes, adjusted for risk factors. Each individual infection was positively, though not significantly, associated with stroke risk after adjusting for other risk factors. The infectious burden index was associated with an increased risk of all strokes (adjusted hazard ratio per standard deviation, 1.39; 95% confidence interval, 1.02-1.90) after adjusting for demographics and risk factors. Results were similar after excluding those with coronary disease (adjusted hazard ratio, 1.50; 95% confidence interval, 1.05-2.13) and adjusting for inflammatory biomarkers. Conclusions: A quantitative weighted index of infectious burden was associated with risk of first stroke in this cohort. Future studies are needed to confirm these findings and to further define optimal measures of infectious burden as a stroke risk factor.

Original languageEnglish (US)
Pages (from-to)33-38
Number of pages6
JournalArchives of Neurology
Volume67
Issue number1
DOIs
StatePublished - Jan 2010

Fingerprint

Stroke
Serologic Tests
Confidence Intervals
Manhattan
Burden
Chlamydophila pneumoniae
Human Herpesvirus 2
Human Herpesvirus 1
Infection
Cytomegalovirus
Proportional Hazards Models
Helicobacter pylori
Coronary Disease
Blood Vessels
Cohort Studies
Biomarkers
Demography
Outcome Assessment (Health Care)
Prospective Studies
Hazard

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

Elkind, M. S. V., Ramakrishnan, P., Moon, Y. P., Boden-Albala, B., Liu, K. M., Spitalnik, S. L., ... Paik, M. C. (2010). Infectious burden and risk of stroke: The northern manhattan study. Archives of Neurology, 67(1), 33-38. https://doi.org/10.1001/archneurol.2009.271

Infectious burden and risk of stroke : The northern manhattan study. / Elkind, Mitchell S V; Ramakrishnan, Pankajavalli; Moon, Yeseon P.; Boden-Albala, Bernadette; Liu, Khin M.; Spitalnik, Steve L.; Rundek, Tanja; Sacco, Ralph L.; Paik, Myunghee C.

In: Archives of Neurology, Vol. 67, No. 1, 01.2010, p. 33-38.

Research output: Contribution to journalArticle

Elkind, MSV, Ramakrishnan, P, Moon, YP, Boden-Albala, B, Liu, KM, Spitalnik, SL, Rundek, T, Sacco, RL & Paik, MC 2010, 'Infectious burden and risk of stroke: The northern manhattan study', Archives of Neurology, vol. 67, no. 1, pp. 33-38. https://doi.org/10.1001/archneurol.2009.271
Elkind, Mitchell S V ; Ramakrishnan, Pankajavalli ; Moon, Yeseon P. ; Boden-Albala, Bernadette ; Liu, Khin M. ; Spitalnik, Steve L. ; Rundek, Tanja ; Sacco, Ralph L. ; Paik, Myunghee C. / Infectious burden and risk of stroke : The northern manhattan study. In: Archives of Neurology. 2010 ; Vol. 67, No. 1. pp. 33-38.
@article{f147abbb3e834c1093b2460bcfc84c2e,
title = "Infectious burden and risk of stroke: The northern manhattan study",
abstract = "Objective: To determine the association between a composite measure of serological test results for common infections (Chlamydia pneumoniae, Helicobacter pylori, cytomegalovirus, and herpes simplex virus 1 and 2) and stroke risk in a prospective cohort study. Design: Prospective cohort followed up longitudinally for median 8 years. Setting: Northern Manhattan Study. Patients: Randomly selected stroke-free participants from a multiethnic urban community. Main Outcome Measure: Incident stroke and other vascular events. Results: All 5 infectious serological results were available from baseline samples in 1625 participants (mean [SD] age, 68.4 [10.1] years; 64.9{\%} women). Cox proportional hazards models were used to estimate associations of each positive serological test result with stroke. Individual parameter estimates were then combined into a weighted index of infectious burden and used to calculate hazard ratios and confidence intervals for association with risk of stroke and other outcomes, adjusted for risk factors. Each individual infection was positively, though not significantly, associated with stroke risk after adjusting for other risk factors. The infectious burden index was associated with an increased risk of all strokes (adjusted hazard ratio per standard deviation, 1.39; 95{\%} confidence interval, 1.02-1.90) after adjusting for demographics and risk factors. Results were similar after excluding those with coronary disease (adjusted hazard ratio, 1.50; 95{\%} confidence interval, 1.05-2.13) and adjusting for inflammatory biomarkers. Conclusions: A quantitative weighted index of infectious burden was associated with risk of first stroke in this cohort. Future studies are needed to confirm these findings and to further define optimal measures of infectious burden as a stroke risk factor.",
author = "Elkind, {Mitchell S V} and Pankajavalli Ramakrishnan and Moon, {Yeseon P.} and Bernadette Boden-Albala and Liu, {Khin M.} and Spitalnik, {Steve L.} and Tanja Rundek and Sacco, {Ralph L.} and Paik, {Myunghee C.}",
year = "2010",
month = "1",
doi = "10.1001/archneurol.2009.271",
language = "English (US)",
volume = "67",
pages = "33--38",
journal = "Archives of Neurology",
issn = "0003-9942",
publisher = "American Medical Association",
number = "1",

}

TY - JOUR

T1 - Infectious burden and risk of stroke

T2 - The northern manhattan study

AU - Elkind, Mitchell S V

AU - Ramakrishnan, Pankajavalli

AU - Moon, Yeseon P.

AU - Boden-Albala, Bernadette

AU - Liu, Khin M.

AU - Spitalnik, Steve L.

AU - Rundek, Tanja

AU - Sacco, Ralph L.

AU - Paik, Myunghee C.

PY - 2010/1

Y1 - 2010/1

N2 - Objective: To determine the association between a composite measure of serological test results for common infections (Chlamydia pneumoniae, Helicobacter pylori, cytomegalovirus, and herpes simplex virus 1 and 2) and stroke risk in a prospective cohort study. Design: Prospective cohort followed up longitudinally for median 8 years. Setting: Northern Manhattan Study. Patients: Randomly selected stroke-free participants from a multiethnic urban community. Main Outcome Measure: Incident stroke and other vascular events. Results: All 5 infectious serological results were available from baseline samples in 1625 participants (mean [SD] age, 68.4 [10.1] years; 64.9% women). Cox proportional hazards models were used to estimate associations of each positive serological test result with stroke. Individual parameter estimates were then combined into a weighted index of infectious burden and used to calculate hazard ratios and confidence intervals for association with risk of stroke and other outcomes, adjusted for risk factors. Each individual infection was positively, though not significantly, associated with stroke risk after adjusting for other risk factors. The infectious burden index was associated with an increased risk of all strokes (adjusted hazard ratio per standard deviation, 1.39; 95% confidence interval, 1.02-1.90) after adjusting for demographics and risk factors. Results were similar after excluding those with coronary disease (adjusted hazard ratio, 1.50; 95% confidence interval, 1.05-2.13) and adjusting for inflammatory biomarkers. Conclusions: A quantitative weighted index of infectious burden was associated with risk of first stroke in this cohort. Future studies are needed to confirm these findings and to further define optimal measures of infectious burden as a stroke risk factor.

AB - Objective: To determine the association between a composite measure of serological test results for common infections (Chlamydia pneumoniae, Helicobacter pylori, cytomegalovirus, and herpes simplex virus 1 and 2) and stroke risk in a prospective cohort study. Design: Prospective cohort followed up longitudinally for median 8 years. Setting: Northern Manhattan Study. Patients: Randomly selected stroke-free participants from a multiethnic urban community. Main Outcome Measure: Incident stroke and other vascular events. Results: All 5 infectious serological results were available from baseline samples in 1625 participants (mean [SD] age, 68.4 [10.1] years; 64.9% women). Cox proportional hazards models were used to estimate associations of each positive serological test result with stroke. Individual parameter estimates were then combined into a weighted index of infectious burden and used to calculate hazard ratios and confidence intervals for association with risk of stroke and other outcomes, adjusted for risk factors. Each individual infection was positively, though not significantly, associated with stroke risk after adjusting for other risk factors. The infectious burden index was associated with an increased risk of all strokes (adjusted hazard ratio per standard deviation, 1.39; 95% confidence interval, 1.02-1.90) after adjusting for demographics and risk factors. Results were similar after excluding those with coronary disease (adjusted hazard ratio, 1.50; 95% confidence interval, 1.05-2.13) and adjusting for inflammatory biomarkers. Conclusions: A quantitative weighted index of infectious burden was associated with risk of first stroke in this cohort. Future studies are needed to confirm these findings and to further define optimal measures of infectious burden as a stroke risk factor.

UR - http://www.scopus.com/inward/record.url?scp=74949140216&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=74949140216&partnerID=8YFLogxK

U2 - 10.1001/archneurol.2009.271

DO - 10.1001/archneurol.2009.271

M3 - Article

VL - 67

SP - 33

EP - 38

JO - Archives of Neurology

JF - Archives of Neurology

SN - 0003-9942

IS - 1

ER -